Singapore markets close in 5 hours 57 minutes
Straits Times Index
3,335.79 +2.99 (+0.09%) Nikkei
39,687.40 +104.32 (+0.26%) Hang Seng
17,718.61 +2.11 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
63,347.29 +2,628.50 (+4.33%) CMC Crypto 200
1,313.85 +30.02 (+2.34%)
Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)
Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
As of 10:48AM CST. Market open.
Currency in CNY
Valuation measures4
| Market cap (intra-day) | 28.68B |
| Enterprise value | 26.01B |
| Trailing P/E | 31.40 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 11.65 |
| Price/book (mrq) | 6.64 |
| Enterprise value/revenue | 10.47 |
| Enterprise value/EBITDA | 27.86 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.50 |
| 52-week change 3 | 123.65% |
| S&P500 52-week change 3 | 22.55% |
| 52-week high 3 | 68.87 |
| 52-week low 3 | 22.16 |
| 50-day moving average 3 | 59.15 |
| 200-day moving average 3 | 44.96 |
Share statistics
| Avg vol (3-month) 3 | 6.2M |
| Avg vol (10-day) 3 | 4.96M |
| Shares outstanding 5 | 450M |
| Implied shares outstanding 6 | 457.48M |
| Float 8 | 196.56M |
| % held by insiders 1 | 61.94% |
| % held by institutions 1 | 4.57% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 0.4 |
| Forward annual dividend yield 4 | 0.63% |
| Trailing annual dividend rate 3 | 0.40 |
| Trailing annual dividend yield 3 | 0.63% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 31 May 2024 |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 36.84% |
| Operating margin (ttm) | 38.47% |
Management effectiveness
| Return on assets (ttm) | 12.48% |
| Return on equity (ttm) | 24.22% |
Income statement
| Revenue (ttm) | 2.48B |
| Revenue per share (ttm) | 5.47 |
| Quarterly revenue growth (yoy) | 168.70% |
| Gross profit (ttm) | N/A |
| EBITDA | 855.75M |
| Net income avi to common (ttm) | 915.35M |
| Diluted EPS (ttm) | 2.03 |
| Quarterly earnings growth (yoy) | 777.50% |
Balance sheet
| Total cash (mrq) | 2.68B |
| Total cash per share (mrq) | 5.95 |
| Total debt (mrq) | 1.5M |
| Total debt/equity (mrq) | 0.03% |
| Current ratio (mrq) | 8.35 |
| Book value per share (mrq) | 9.60 |
Cash flow statement
| Operating cash flow (ttm) | 1.06B |
| Levered free cash flow (ttm) | 556.74M |
© 2024 Yahoo. All rights reserved.